`Patent 7,772,209
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`NEPTUNE GENERICS, LLC,
`Petitioner,
`
`v.
`
`ELI LILLY & COMPANY,
`Patent Owner.
`__________________
`
`Case No: IPR2016-00240
`Patent No. 7,772,209
`__________________
`
`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`
`
`Case IPR2016-00240
`Patent 7,772,209
`
`EXHIBIT
`
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`2008
`
`2009
`
`2010
`
`2011
`
`DESCRIPTION
`Lilly Eli & Co. Form 10-k Annual Report filed February 19, 2016 for the
`Period Ending December 31, 2015
`Alimta Prescribing Information revised September 2013
`Eli Lilly and Co. v. Teva Parenteral Medicines Inc. et al., Civil Action
`No. 1:10-cv-01376, Defendants’ Opening Post-Trial Brief Regarding the
`Invalidity of U.S. Patent No. 7,772,209, dated October 11, 2013
`Eli Lilly and Co. v. Teva Parenteral Medicines Inc. et al., Civil Action
`No. 1:10-cv-01376, Plaintiff Eli Lilly and Company’s Post-Trial Brief,
`dated November 22, 2013
`Eli Lilly and Co. v. Teva Parenteral Medicines Inc. et al., Civil Action
`No. 1:10-cv-01376, Defendants’ Trial Brief Regarding the Invalidity of
`U.S. Patent No. 7,772,209, dated June 14, 2013
`Eli Lilly and Co. v. Teva Parenteral Medicines Inc. et al., Civil Action
`No. 1:10-cv-01376, Joint Trial Exhibit List, dated August 18, 2013
`Eli Lilly and Co. v. Teva Parenteral Medicines Inc. et al., Civil Action
`No. 1:10-cv-01376, Official Reporter’s Transcript of Bench Trial
`Volume VI, dated August 26, 2013
`Eli Lilly and Co. v. Teva Parenteral Medicines et al., United States Court
`of Appeals for the Federal Circuit Case 15-2067, Notice of Docketing,
`dated September 25, 2015
`Eli Lilly and Co. v. Teva Parenteral Medicines et al., United States Court
`of Appeals for the Federal Circuit Case 15-2067, Order on Motion to
`Modify Briefing Schedule, dated November 5, 2015
`United States Court of Appeals for the Federal Circuit Internal Operating
`Procedures
`Eli Lilly and Co. v. Teva Parenteral Medicines Inc. et al., Civil Action
`No. 1:10-cv-01376, Official Reporter’s Transcript of Bench Trial
`Volume VII, dated August 27, 2013
`
`2012
`
`Exhibit Number Not Used
`
`
`
`Case IPR2016-00240
`Patent 7,772,209
`
`2013
`
`2014
`
`2015
`
`2016
`
`2017
`
`2018
`
`Exhibit Number Not Used
`
`Exhibit Number Not Used
`
`Exhibit Number Not Used
`
`Exhibit Number Not Used
`
`Exhibit Number Not Used
`
`Affidavit of Adam L. Perlman In Support of Motion for Pro Hac Vice
`Admission Pursuant to 37 C.F.R. § 42.10(c)
`
`Date: July 8, 2016
`
`Respectfully submitted,
`
`/Dov P. Grossman/
`Dov P. Grossman
`Reg. No. 72,525
`Lead Counsel for
`Patent Owner
`
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, D.C. 20005
`202-434-5812 (Telephone)
`202-434-5029 (Facsimile)
`dgrossman@wc.com
`
`
`
`Case IPR2016-00240
`Patent 7,772,209
`
`CERTIFICATE OF SERVICE
`(37 C.F.R. §§ 42.6(e))
`
`The undersigned hereby certifies that the document above was served on
`
`this 8th day of July, 2016, on the Petitioner by delivering a copy via electronic mail
`
`to the following individuals at the email addresses below:
`
`Sarah E. Spires
`Reg. No. 61,501
`240Neptune@skiermontderby.com
`
`Dr. Parvathi Kota
`Reg. No. 65,122
`240Neptune@skiermontderby.com
`
`Skiermont Derby LLP
`2200 Ross Ave., Ste. 4800W
`Dallas, Texas 75201
`P: 214-978-6600/F: 214-978-6601
`
`Date: July 8, 2016
`
`/Dov P. Grossman/
`Dov P. Grossman
`Attorney for Patent Owner
`Registration No. 72,525
`Lead Counsel for Patent Owner